Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad, Harvard Bio Lead Declines in BCW Index

Bio-Rad Laboratories and Harvard Bioscience had the sharpest declines in stock price among the multi-platform molecular biology tool firms that comprise the BCW Index. Of the 15 companies tracked by BioCommerce Week, 13 ended the weekly tracking period down — the exceptions being Applied Biosystems and Stratagene.

Bio-Rad dropped nearly 11 percent following the release of second-quarter results, which showed a 9.3 percent drop in profits and surging SG&A costs (see related article). Harvard Bio's stock fell nearly 10 percent, as the firm posted a massive net loss due to impairment charges (see related article).

Overall, the Index declined 2.8 percent, which wasn't as poor of a performance as that turned in by the Nasdaq Biotech Index, which fell 4.1 percent over the same period. The broader Nasdaq dropped 2 percent for the week, and the Dow Jones Industrial Average slipped .6 percent.

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
August 9, 2005)
Last Price
(
August 2, 2005)
% Change
Agilent
A
25.58
26.63
-3.94
Applied Biosystems
ABI
21.15
21.08
0.33
Beckman
BEC
52.95
54
-1.94
Bio-Rad
BIO
55.75
62.52
-10.83
Bruker
BRKR
4.1
4.23
-3.07
GE
GE
34.14
34.25
-0.32
Harvard Bio
HBIO
3.09
3.42
-9.65
Invitrogen
IVGN
85.7
86.14
-0.51
Molecular Devices
MDCC
20.36
21.06
-3.32
PerkinElmer
PKI
20.32
20.75
-2.07
Qiagen
QGEN
12.86
13.48
-4.60
Sigma
SIAL
62.01
63.81
-2.82
Strategene
STGN
10.2
10
2.00
Thermo
TMO
28.9
29.49
-2.00
Waters
WAT
44.91
45.07
-0.36
Index Average  
32.13
33.06
-2.80